Hlb Genex Inc. (187420) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hlb Genex Inc. (187420:KRX), powered by AI.
- Current Price
- ₩2,375
- P/E Ratio
- 3.4
- Market Cap
- 77.3B
- Sector
- Basic Materials
What is the Hlb Genex Inc. stock price forecast?
Hlb Genex Inc. is currently trading at ₩2,375. View real-time AI analysis on Alpha Lenz.
What is Hlb Genex Inc. insider trading activity?
View the latest insider trading data for Hlb Genex Inc. on Alpha Lenz.
What is Hlb Genex Inc.'s P/E ratio?
Hlb Genex Inc.'s P/E ratio is 3.4.
Hlb Genex Inc.
KRX · 187420“Hlb Genex Inc. trades at a P/E of 3.4 (undervalued) with strong ROE of 69.8%. 3Y revenue CAGR of 16.0% highlights clear growth momentum.”
Ask for details →Company Overview
Hlb Genex Inc. operates as a dynamic player in the biotechnology sector. Dedicated to advancing healthcare solutions, the company focuses on the research, development, and commercialization of innovative medical therapies and diagnostic tools. By leveraging cutting-edge biotechnological processes, Hlb Genex Inc. aims to address unmet medical needs and improve patient outcomes. Its activities span various areas within the biosciences industry, impacting sectors such as pharmaceuticals, healthcare, and wellness. The firm's commitment to scientific advancement and clinical excellence positions it as a pivotal entity in the quest for medical innovation, contributing to the overall growth and evolution of the biotechnological landscape within the financial market.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Hlb Genex Inc. trades at a P/E of 3.4 (undervalued) with strong ROE of 69.8%. 3Y revenue CAGR of 16.0% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
Hlb Genex Inc. (ticker: 187420) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). It has approximately 79 employees. Market cap is $77.3B.
The current price is ₩2,375 with a P/E ratio of 3.42x and P/B of 1.89x.
ROE is 69.85% and operating margin is 2.94%. Annual revenue is $43.4B.